JCRC Research Bulletin 2024 [Download]

It is with great pride that I share with you this latest edition of the Joint Clinical Research Centre (JCRC) Research Bulletin, a reflection of our tireless efforts and continued commitment to advancing clinical research in Uganda and the world at large. As an institution founded on scientific excellence, JCRC continues to play a central role in addressing major public health challenges through research driven solutions.

Over the past year, our dedicated researchers and collaborators have made significant progress in a number of impactful studies. These include a Phase III COVID-19 vaccine trial, which demonstrated the Centre’s readiness to contribute to pandemic response through vaccine research. We also participated in the IMPAACT 2032 study, enrolling infants in a clinical trial to monitor drug exposure through breastmilk, which will help optimize treatment safety for both mothers and children. Our research team has also led efforts in the OPTIMISE study, evaluating a novel therapeutic strategy to improve treatment outcomes among people living with HIV.

Additionally, JCRC’s leadership in the CURE Africa Uganda study continues to position the Centre at the forefront of efforts to find a cure for HIV. This important work has been complemented by the launch of the first ever Community HIV Cure Symposium in Uganda, hosted by the Cross-CAB under the leadership of Mr. Super Charger. The event brought together community representatives, civil society organizations, researchers, and international experts, and marked the unveiling of the Community HIV Cure Art Gallery, a new educational resource.